Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun

Metastasis is the leading cause of human cancer deaths. Unfortunately, no approved drugs are available for anti-metastatic treatment. In our study, high-throughput sequencing-based high-throughput screening (HTS(2)) and a breast cancer lung metastasis (BCLM)-associated gene signature were combined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Wei, Li, Shasha, Li, Lu, Lin, Kequan, Liu, Xinhong, Wang, Haiyan, Wang, Huili, Wang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338618/
https://www.ncbi.nlm.nih.gov/pubmed/29667003
http://dx.doi.org/10.1007/s13238-018-0533-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338618/
https://www.ncbi.nlm.nih.gov/pubmed/29667003
http://dx.doi.org/10.1007/s13238-018-0533-8

Ejemplares similares